ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Scientific Session 1: Top Scoring Abstracts 2018
15:24

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Skeletal Muscle Toxicity Associated with Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia

FEATURING Lando Janssen
  • 9 views
  • January 2, 2019
16:25

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Spirit 2: Final Analysis of an NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

FEATURING Stephen O'Brien
  • 17 views
  • January 2, 2019
16:00

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Nilotinib vs. Nilotinib Plus Interferon α Induction and Nilotinib or Interferon α Maintenance Therapy for Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V) Trial

FEATURING Andreas Hochhaus
  • 16 views
  • January 18, 2019